Menu Close

Artikel-artikel mengenai Generic medicines

Menampilkan semua artikel

Drug patents don’t necessarily spur companies to innovate so much as restrict access to their IP. Andrii Zastrozhnov/iStock via Getty Images Plus

Pharma’s expensive gaming of the drug patent system is successfully countered by the Medicines Patent Pool, which increases global access and rewards innovation

The Medicines Patent Pool was created to promote public health, facilitating generic licensing for patented drugs that treat diseases predominantly affecting low- and middle-income countries.
Generic drug names are assigned at the global level by the World Health Organization in conjunction with national naming authorities. (Shutterstock)

Generic drug names provide information for doctors, so why is Health Canada promoting the use of pharma brand names?

Generic drug names are often long, but they can tell doctors what type of medicine it is and how it works. But it’s brand names that appear first and most prominently in Health Canada materials.
Research shows that the number of drug shortages in Canada are increasing, even though patients may not be aware of it. (Shutterstock))

The creeping problem of drug shortages

The Canadian government must undertake regular analysis of the drug shortage problem, if we are ever to develop sustainable solutions.
Representatives of the 12 Trans-Pacific Partnership (TPP) member countries at a press conference in Atlanta, after a deal was reached. EPA/Erik S. Lesser

Why biologics were such a big deal in the Trans Pacific Partnership

Before the last round of negotiations, only a handful of issues remained in the way of concluding the TPP. A potential deal-breaker for Australia was intellectual property protections for biologics.
If the proposals are agreed, they could delay the market entry of generic medicines in the region – and the impact will be felt around the world. Jeng_Niamwhan

RCEP: the trade agreement you’ve never heard of but should be concerned about

Seven rounds of negotiations for the Regional Comprehensive Economic Partnership have already taken place with virtually no public debate. The next round of negotiations begins today in Kyoto, Japan.
Generics aren’t always so cheap. Pill bottles via bikeriderlondon/Shutterstock

Why are some generic drugs getting so expensive?

More than eight out of every 10 prescriptions dispensed in the US is generic. This growth is due to a large number of top-selling drugs going off patent over the past decade, as well as innovations in…
Drug companies invent hundreds of new molecules that they hope to turn into saleable medicines. Keith Ramsey

Can’t pronounce the name of your medicine? Here’s why

Gone are the good old days when medicines had simple, easy to pronounce names such as aspirin, paracetamol and morphine. Nowadays pharmaceutical companies almost seem to revel in giving drugs names that…
Harder times ahead for Pfizer as Viagra patents end. Flickr/kosare

End of an era for Viagra as rivals get ready to raid market

Those for whom Viagra is indispensable might be a little surprised that the ubiquitous blue, diamond-shaped pill was a chance discovery by a group of research pharmaceutical chemists at Pfizer’s research…
A Greens/EFA MEPs protest against ACTA at the European Parliament in Strasbourg. The protestors urged their fellow members to join them in standing up for democracy and a free internet. ©Photo European Union

Opening Pandora’s box: secret treaty threatens human rights

The Anti-Counterfeiting Trade Agreement (ACTA) 2011 - Twitter hashtag #ACTA - is a controversial trade agreement designed to provide for stronger enforcement of intellectual property rights. There’s been…

Kontributor teratas

Lebih banyak